Sensyne Health PLC
LSE:SENS
Sensyne Health PLC
LSE:SENS
Price:
0.35 GBX
-33.33%
Market Closed
Updated:
May 21, 2024
P/E
Price to Earnings
Price to Earnings
-0
Current
-0
Median
24.1
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-0
Market Cap
/
576.8k
Net Income
-34.8m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| UK |
|
Sensyne Health PLC
LSE:SENS
|
576.8k GBP | -0 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
33.9B USD | 64.5 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 47.3 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | -116.8 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.8B AUD | 168.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 23.7 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
5.3B USD | 35.8 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
4.7B USD | -295.3 | |
| SE |
|
Sectra AB
STO:SECT B
|
45.7B SEK | 107.7 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | -324 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.7B USD | -404.1 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
N/A
2-Years Forward
P/E
0
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
